Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
New York, NY
NPI: 1265595649HQ Phone
Get M.D. Peter's Phone Numberphone_androidMobile
Get M.D. Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardJohns Hopkins University
Residency • Internal Medicine
1970 - 1971
The MetroHealth System/Case Western Reserve University
Residency • Internal Medicine
1969 - 1970
Internship • Internal Medicine
1965 - 1966
University of Virginia School of Medicine
Medical School
Until 1965
National Institutes of Health Clinical Center
Fellowship • Medical Oncology
—
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia.
Authors: Hugo Fernandez, Selina Luger, Martin Tallman, Larry Cripe, Mark Litzow
Journal: Br J Haematol
Publication Date: 2021-06-17
Optimal Therapy for Adult Patients with Acute Myeloid Leukemia in First Complete Remission
Authors: Peter H. Wiernik
Publication Date: 2014-05
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: Bristol-Myers Squibb, Sanofi, National Cancer Institute (NCI), Pfizer, Eastern Cooperative Oncology Group
Intervention / Treatment: BIOLOGICAL: cetuximab, DRUG: FOLFOX, DRUG: ECF, DRUG: IC
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: alemtuzumab, DRUG: dexamethasone, DRUG: methotrexate, DRUG: mercaptopurine, DRUG: vincristine, DRUG: leucovorin calcium, DRUG: asparaginase
Lead Sponsor: Bristol-Myers Squibb
Collaborators: ICON Clinical Research